Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Wilms Tumor × Isotretinoin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 19 Lung Neoplasms 3 Gliosarcoma 3 Glioma 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Oligodendroglioma 2 Neoplasms 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Kidney Neoplasms 2 Central Nervous System Neoplasms 2 Astrocytoma 2 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Penile Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms, Second Primary 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Multiple Myeloma 1

Interventions

Cyclophosphamide 9 Filgrastim 8 Granulocyte Colony-Stimulating Factor 6 Melphalan 5 Busulfan 5 Vincristine 4 Temozolomide 4 Stem Cell Transplantation 4 Peripheral Blood Stem Cell Transplantation 4 Ifosfamide 4 Etoposide 4 fludarabine 3 Topotecan 3 Radiotherapy 3 Mesna 3 Itraconazole 3 Doxorubicin 3 Cisplatin 3 sargramostim 2 fludarabine phosphate 2 Thiotepa 2 Therapeutics 2 Sirolimus 2 Radiotherapy, Intensity-Modulated 2 Nivolumab 2 Drug Therapy 2 Carboplatin 2 Bone Marrow Transplantation 2 Blood Specimen Collection 2 Amplified Fragment Length Polymorphism Analysis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡